Launch HN: RonanRX (YC S26) – Personalized Peptides and GLP-1s
Summary
RonanRx presents a physician-led, patient-specific GLP-1 therapy platform that personalizes dosing and adjuncts, with pharmacist-verified release and a strict chain of authority. It emphasizes HIPAA-compliant data privacy and notes that compounded medications are not FDA-approved, with pricing considerations discussed.